Dr. Arvind Parmar, Dr. Giancarlo Pascali and Dr. Orazio Vittorio of CCI led the development of a new PET imaging protocol using small quantity of the radioactive form of copper chloride that measured in vivo neuroblastoma tumor response to the drug Dextran-Catechin in a pre-clinical laboratory model.  {read more here}